ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
Dow Jones
39.512,84
0,32%
Euro vs US Dollar
1,077
0,00%
Bitcoin
61.513,48
0,11%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Standard BioTools Inc (LAB)

  7. Standard BioTools Inc (LAB) News

LAB Standard BioTools Inc

2,34
-0,07 (-2,90%)
11 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Standard BioTools Inc LAB NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
-0,07 -2,90% 2,34 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
2,40 2,38 2,47 2,40 2,41
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
10.5.202423:16EDGAR2Form PREC14A - Preliminary proxy statements, contested..
09.5.202422:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.5.202422:31EDGAR2Form 8-K - Current report
08.5.202422:01GLOBEStandard BioTools Reports First Quarter 2024 Financial..
25.4.202414:01GLOBEStandard BioTools Announces Operational Restructuring Plan..
25.4.202414:00GLOBEStandard BioTools Announces Conference Call and Webcast for..
08.4.202414:00GLOBEStandard BioTools Introduces New High-Throughput Multiplexed..
03.4.202422:01GLOBEStandard BioTools Announces Multi-Year Strategic Engagement..
18.3.202413:12GLOBEStandard BioTools Announces Exchange of All Outstanding..
07.3.202401:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202422:05EDGAR2Form 8-K - Current report
28.2.202422:01GLOBEStandard BioTools Reports Fourth Quarter and Full Year 2023..
26.2.202422:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26.2.202414:00GLOBEStandard BioTools and Next Gen Diagnostics Announce..
22.2.202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202422:05GLOBEStandard BioTools to Participate in Upcoming Investor..
14.2.202421:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202414:30GLOBEStandard BioTools Announces Conference Call and Webcast for..
08.2.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
07.2.202414:30GLOBEStandard BioTools and Navignostics Announce Collaboration..
02.2.202422:49EDGAR2Form S-3/A - Registration statement under Securities Act of..
19.1.202423:07EDGAR2Form S-3 - Registration statement under Securities Act of..
19.1.202423:05EDGAR2Form S-3 - Registration statement under Securities Act of..
19.1.202423:03EDGAR2Form S-8 - Securities to be offered to employees in employee..
19.1.202422:48EDGAR2Form S-8 - Securities to be offered to employees in employee..
19.1.202422:33EDGAR2Form 8-K/A - Current report: [Amend]
12.1.202420:04EDGAR2Form SC 13D/A - General statement of acquisition of..
10.1.202402:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202400:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
10.1.202400:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
10.1.202400:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
09.1.202423:13EDGAR2Form SC 13D/A - General statement of acquisition of..
08.1.202423:00EDGAR2Form SC 13D/A - General statement of acquisition of..
08.1.202414:39EDGAR2Form 8-K - Current report
08.1.202414:30GLOBEStandard BioTools Announces Preliminary Fourth Quarter and..
05.1.202414:53EDGAR2Form 8-K - Current report
05.1.202414:46GLOBEStandard BioTools Completes Merger with SomaLogic, Creating..
05.1.202404:23GLOBEStandard BioTools Stockholders Approve Merger with SomaLogic
05.1.202403:44PRNUSSomaLogic Stockholders Vote to Approve Standard BioTools..
29.12.202323:26EDGAR2Form 425 - Prospectuses and communications, business..
29.12.202323:25EDGAR2Form 8-K - Current report
29.12.202323:04GLOBEGlass Lewis Recommends Standard BioTools Stockholders Vote..
28.12.202322:16PRNUSDr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to..
26.12.202321:59PRNUSSomaLogic Issues Statement Correcting Madryn Asset..
23.12.202300:57GLOBEISS Recommends Standard BioTools Stockholders Vote “FOR” All..
21.12.202314:00GLOBESomaLogic Issues Letter to Stockholders Reiterating..

Kürzlich von Ihnen besucht

NASDAQ
LAB
Standard BioTools
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten